The plasmodium falciparum-specific human memory b cell compartment expands gradually with repeated malaria infections

PLoS Pathogens

Volumn 6, Issue 5, 2010, Pages 1-13

  Weiss, Greta E ^a   Traore, Boubacar ^b   Kayentao, Kassoum ^b   Ongoiba, Aissata ^b   Doumbo, Safiatou ^b   Doumtabe, Didier ^b   Kone, Younoussou ^b   Dia, Seydou ^b   Guindo, Agnes ^b   Traore, Abdramane ^b   Huang, Chiung Yu ^a   Miura, Kazutoyo ^a   Mircetic, Marko ^a   Li, Shanping ^a   Baughman, Amy ^a   Narum, David L ^a   Miller, Louis H ^a   Doumbo, Ogobara K ^b   Pierce, Susan K ^a   Crompton, Peter D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF BAMAKO   (Mali)

Author keywords

[No Author keywords available]

Indexed keywords

PARASITE ANTIBODY; TETANUS TOXOID; IMMUNOGLOBULIN G; PROTOZOON ANTIBODY;

ADULT; AGE; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; CELL COMPARTMENTALIZATION; CELL EXPANSION; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MALI; MEMORY CELL; NONHUMAN; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PROSPECTIVE STUDY; SCHOOL CHILD; TETANUS; ACUTE DISEASE; ADOLESCENT; B LYMPHOCYTE; BLOOD; DISEASE TRANSMISSION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; IMMUNOPHENOTYPING; LONGITUDINAL STUDY; PARASITOLOGY; RECURRENT DISEASE; SEASON;

PLASMODIUM FALCIPARUM;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIBODIES, PROTOZOAN; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; LONGITUDINAL STUDIES; MALARIA, FALCIPARUM; MALE; MALI; PLASMODIUM FALCIPARUM; PROSPECTIVE STUDIES; RECURRENCE; SEASONS; YOUNG ADULT;

EID: 77954052505     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000912     Document Type: Article

References (71)

1. Plotkin SA (2008) Vaccines: correlates of vaccine-induced immunity. Clin Infect Dis 47: 401-409.
2. Vekemans J, Ballou WR (2008) Plasmodium falciparum malaria vaccines in development. Expert Rev Vaccines 7: 223-240.
3. Marsh K, Kinyanjui S (2006) Immune effector mechanisms in malaria. Parasite Immunol 28: 51-60.
4. Cohen S, Mc GI, Carrington S (1961) Gamma-globulin and acquired immunity to human malaria. Nature 192: 733-737.
5. Langhorne J, Ndungu FM, Sponaas AM, Marsh K (2008) Immunity to malaria: more questions than answers. Nat Immunol 9: 725-732.
6. Gourley TS, Wherry EJ, Masopust D, Ahmed R (2004) Generation and maintenance of immunological memory. Semin Immunol 16: 323-333.
7. Tarlinton DM (2008) Evolution in miniature: selection, survival and distribution of antigen reactive cells in the germinal centre. Immunol Cell Biol 86: 133-138.
8. Manz RA, Thiel A, Radbruch A (1997) Lifetime of plasma cells in the bone marrow. Nature 388: 133-134.
9. Zinkernagel RM, Bachmann MF, Kundig TM, Oehen S, Pirchet H, et al. (1996) On immunological memory. Annu Rev Immunol 14: 333-367.
10. Bernasconi NL, Traggiai E, Lanzavecchia A (2002) Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298: 2199-2202.
11. Macallan DC, Wallace DL, Zhang Y, Ghattas H, Asquith B, et al. (2005) B-cell kinetics in humans: rapid turnover of peripheral blood memory cells. Blood 105: 3633-3640.
12. Greenwood BM, Vick RM (1975) Evidence for a malaria mitogen in human malaria. Nature 257: 592-594.
13. Donati D, Zhang LP, Chene A, Chen Q, Flick K, et al. (2004) Identification of a polyclonal B-cell activator in Plasmodium falciparum. Infect Immun 72: 5412-5418.
14. Crompton PD, Traore B, Kayentao K, Doumbo S, Ongoiba A, et al. (2008) Sickle Cell Trait Is Associated with a Delayed Onset of Malaria: Implications for Time-to-Event Analysis in Clinical Studies of Malaria. J Infect Dis 198: 1265-1275.
15. (2000) Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 94 Suppl 1: S1-90.
16. Crompton PD, Mircetic M, Weiss G, Baughman A, Huang CY, et al. (2009) The TLR9 ligand CpG promotes the acquisition of Plasmodium falciparumspecific memory B cells in malaria-naïve individuals. J Immunol 182: 3318-3326.
17. Dicko A, Klion AD, Thera MA, Sagara I, Yalcouye D, et al. (2004) The etiology of severe anemia in a village and a periurban area in Mali. Blood 104: 1198-1200.
18. Weiss GE, Crompton PD, Li S, Walsh LA, Moir S, et al. (2009) Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. J Immunol 183: 2176-2182.
19. Moir S, Ho J, Malaspina A, Wang W, DiPoto AC, et al. (2008) Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med 205: 1797-1805.
20. Sagara I, Dicko A, Ellis RD, Fay MP, Diawara SI, et al. (2009) A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali. Vaccine 27: 3090-3098.
21. Ogutu BR, Apollo OJ, McKinney D, Okoth W, Siangla J, et al. (2009) Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya. PLoS One 4: e4708.
22. Wipasa J, Suphavilai C, Okell LC, Cook J, Corran PH, et al. Long-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax. PLoS Pathog 6: e1000770.
23. Dogan I, Bertocci B, Vilmont V, Delbos F, Megret J, et al. (2009) Multiple layers of B cell memory with different effector functions. Nat Immunol 10: 1292-1299.
24. Anderson SM, Tomayko MM, Ahuja A, Haberman AM, Shlomchik MJ (2007) New markers for murine memory B cells that define mutated and unmutated subsets. J Exp Med 204: 2103-2114.
25. Baer J, Santiago F, Yang H, Wu H, Holden-Wiltse J, et al. B cell responses to H5 influenza HA in human subjects vaccinated with a drifted variant. Vaccine 28: 907-915.
26. Wrammert J, Smith K, Miller J, Langley WA, Kokko K, et al. (2008) Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453: 667-671.
27. Miller JD, van der Most RG, Akondy RS, Glidewell JT, Albott S, et al. (2008) Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity 28: 710-722.
28. Harris AM, Bhuiyan MS, Chowdhury F, Khan AI, Hossain A, et al. (2009) Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh. Infect Immun 77: 3850-3856.
29. Morell A, Terry WD, Waldmann TA (1970) Metabolic properties of IgG subclasses in man. J Clin Invest 49: 673-680.
30. Cavanagh DR, Elhassan IM, Roper C, Robinson VJ, Giha H, et al. (1998) A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan. J Immunol 161: 347-359.
31. Kinyanjui SM, Conway DJ, Lanar DE, Marsh K (2007) IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life. Malar J 6: 82.
32. Amanna IJ, Carlson NE, Slifka MK (2007) Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 357: 1903-1915.
33. Crompton PD, Kayala MA, Traore B, Kayentao K, Ongoiba A, et al. A prospective analysis of the antibody response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc Natl Acad Sci U S A. In press.
34. Crotty S, Felgner P, Davies H, Glidewell J, Villarreal L, et al. (2003) Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 171: 4969-4973.
35. Dorfman JR, Bejon P, Ndungu FM, Langhorne J, Kortok MM, et al. (2005) B cell memory to 3 Plasmodium falciparum blood-stage antigens in a malariaendemic area. J Infect Dis 191: 1623-1630.
36. Scherf A, Lopez-Rubio JJ, Riviere L (2008) Antigenic variation in Plasmodium falciparum. Annu Rev Microbiol 62: 445-470.
37. Takala SL, Plowe CV (2009) Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'. Parasite Immunol 31: 560-573.
38. Ruben FL, Smith EA, Foster SO, Casey HL, Pifer JM, et al. (1973) Simultaneous administration of smallpox, measles, yellow fever, and diphtheria-pertussis-tetanus antigens to Nigerian children. Bull World Health Organ 48: 175-181.
39. Delgado MF, Coviello S, Monsalvo AC, Melendi GA, Hernandez JZ, et al. (2009) Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat Med 15: 34-41.
40. Traore B, Kone Y, Doumbo S, Doumtabe D, Traore A, et al. (2009) The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum-specific memory B cells in semi-immune adults in Mali. Vaccine.
41. Wykes MN, Zhou YH, Liu XQ, Good MF (2005) Plasmodium yoelii can ablate vaccine-induced long-term protection in mice. J Immunol 175: 2510-2516.
42. Zellweger RM, Hangartner L, Weber J, Zinkernagel RM, Hengartner H (2006) Parameters governing exhaustion of rare T cell-independent neutralizing IgMproducing B cells after LCMV infection. Eur J Immunol 36: 3175-3185.
43. Carvalho LJ, Ferreira-da-Cruz MF, Daniel-Ribeiro CT, Pelajo-Machado M, Lenzi HL (2007) Germinal center architecture disturbance during Plasmodium berghei ANKA infection in CBA mice. Malar J 6: 59.
44. Achtman AH, Khan M, MacLennan IC, Langhorne J (2003) Plasmodium chabaudi chabaudi infection in mice induces strong B cell responses and striking but temporary changes in splenic cell distribution. J Immunol 171: 317-324.
45. Schmidlin H, Diehl SA, Blom B (2009) New insights into the regulation of human B-cell differentiation. Trends Immunol 30: 277-285.
46. O'Connor BP, Raman VS, Erickson LD, Cook WJ, Weaver LK, et al. (2004) BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med 199: 91-98.
47. Weill JC, Weller S, Reynaud CA (2009) Human marginal zone B cells. Annu Rev Immunol 27: 267-285.
48. Querec TD, Akondy RS, Lee EK, Cao W, Nakaya HI, et al. (2009) Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 10: 116-125.
49. Ehrhardt GR, Hsu JT, Gartland L, Leu CM, Zhang S, et al. (2005) Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells. J Exp Med 202: 783-791.
50. Simpson JA, Aarons L, Collins WE, Jeffery GM, White NJ (2002) Population dynamics of untreated Plasmodium falciparum malaria within the adult human host during the expansion phase of the infection. Parasitology 124: 247-263.
51. West DJ, Calandra GB (1996) Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine 14: 1019-1027.
52. Curtain CC, Kidson C, Champness DL, Gorman JG (1964) Malaria Antibody Content of Gamma 2-7s Globulin in Tropical Populations. Nature 203: 1366-1367.
53. Di Genova G, Roddick J, McNicholl F, Stevenson FK (2006) Vaccination of human subjects expands both specific and bystander memory T cells but antibody production remains vaccine specific. Blood 107: 2806-2813.
54. Ahuja A, Anderson SM, Khalil A, Shlomchik MJ (2008) Maintenance of the plasma cell pool is independent of memory B cells. Proc Natl Acad Sci U S A 105: 4802-4807.
55. Richard K, Pierce SK, Song W (2008) The agonists of TLR4 and 9 are sufficient to activate memory B cells to differentiate into plasma cells in vitro but not in vivo. J Immunol 181: 1746-1752.
56. Florens L, Washburn MP, Raine JD, Anthony RM, Grainger M, et al. (2002) A proteomic view of the Plasmodium falciparum life cycle. Nature 419: 520-526.
57. Daniel-Ribeiro CT, Zanini G (2000) Autoimmunity and malaria: what are they doing together? Acta Trop 76: 205-221.
58. Zanini GM, De Moura Carvalho LJ, Brahimi K, De Souza-Passos LF, Guimaraes SJ, et al. (2009) Sera of patients with systemic lupus erythematosus react with plasmodial antigens and can inhibit the in vitro growth of Plasmodium falciparum. Autoimmunity 42: 545-552.
59. Benson MJ, Elgueta R, Schpero W, Molloy M, Zhang W, et al. (2009) Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals. J Exp Med 206: 2013-2025.
60. Donati D, Mok B, Chene A, Xu H, Thangarajh M, et al. (2006) Increased B cell survival and preferential activation of the memory compartment by a malaria polyclonal B cell activator. J Immunol 177: 3035-3044.
61. Krishnegowda G, Hajjar AM, Zhu J, Douglass EJ, Uematsu S, et al. (2005) Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J Biol Chem 280: 8606-8616.
62. Parroche P, Lauw FN, Goutagny N, Latz E, Monks BG, et al. (2007) Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc Natl Acad Sci U S A 104: 1919-1924.
63. Jones KR, Hickling JK, Targett GA, Playfair JH (1990) Polyclonal in vitro proliferative responses from nonimmune donors to Plasmodium falciparum malaria antigens require UCHL1+ (memory) T cells. Eur J Immunol 20: 307-315.
64. Ho M, Tongtawe P, Kriangkum J, Wimonwattrawatee T, Pattanapanyasat K, et al. (1994) Polyclonal expansion of peripheral gamma delta T cells in human Plasmodium falciparum malaria. Infect Immun 62: 855-862.
65. Hviid L, Kurtzhals JA, Adabayeri V, Loizon S, Kemp K, et al. (2001) Perturbation and proinflammatory type activation of V delta 1(+) gamma delta T cells in African children with Plasmodium falciparum malaria. Infect Immun 69: 3190-3196.
66. Good KL, Avery DT, Tangye SG (2009) Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells. J Immunol 182: 890-901.
67. Wykes MN, Good MF (2009) What have we learnt from mouse models for the study of malaria? Eur J Immunol 39: 2004-2007.
68. Mestas J, Hughes CC (2004) Of mice and not men: differences between mouse and human immunology. J Immunol 172: 2731-2738.
69. Davis MM (2008) A prescription for human immunology. Immunity 29: 835-838.
70. Miura K OA, Muratova OV, Miller LH, Saul A, Long CA (2008) Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines. Vaccine 26: 193-200.
71. Crotty S, Aubert RD, Glidewell J, Ahmed R (2004) Tracking human antigenspecific memory B cells: a sensitive and generalized ELISPOT system. J Immunol Methods 286: 111-122.